RESEARCH

 CURRENT OPPORTUNITIES FOR YOU TO BE INVOLVED

SENSCIS

(Safety and Efficacy of Nintedanib in Systemic SClerosIS)

study at Liverpool Hospital, NSW

being conducted by Principal Investigator at Liverpool Hospital,

Dr Vivek Thakkar

Please CLICK HERE for details

INVESTIGATING THE ROLE OF

THE IMMUNE RESPONSE TO DISEASE PATHOGENESIS

IN SCLERODERMA

being conducted by Dr Ma, The Garvan Institute, Sydney

Please CLICK HERE for details

2015

We are proud to announce that Scleroderma NSW is currently funding the research project:

Perspectives and preferences of patients living with systemic sclerosis (scleroderma)

being undertaken by Dr V. Thakkar at Liverpool Hospital in Sydney. 

 

Thank you to all the Scleroderma NSW members who volunteered their time to participate in this study.

Scleroderma NSW contributes, on an ongoing basis, to the Annual Research Program run by Scleroderma Australia.

In recent years this program has funded the ASIG (Australian Scleroderma Interest Group) by way of a Fellowship Grant.

© 2015 Scleroderma Association of NSW Inc.  |   ABN: 94 989 217 688   |    CFN: 14819